AI Buyer Insights:

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Michelin, an e2open customer evaluated Oracle Transportation Management

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

List of Signant SmartSignals eCOA Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Pfizer Life Sciences 81000 $63.6B United States Signant Health Signant SmartSignals eCOA Clinical Trial Management 2020 n/a
Shionogi Life Sciences 4955 $2.9B Japan Signant Health Signant SmartSignals eCOA Clinical Trial Management 2021 n/a
Showing 1 to 2 of 2 entries

Buyer Intent: Companies Evaluating Signant SmartSignals eCOA

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Signant SmartSignals eCOA. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Signant SmartSignals eCOA Coverage

Signant SmartSignals eCOA is a Clinical Trial Management solution from Signant Health.

Companies worldwide use Signant SmartSignals eCOA, from small firms to large enterprises across 21+ industries.

Organizations such as Pfizer and Shionogi are recorded users of Signant SmartSignals eCOA for Clinical Trial Management.

Companies using Signant SmartSignals eCOA are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Signant SmartSignals eCOA are most concentrated in United States and Japan, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Signant SmartSignals eCOA across Americas, EMEA, and APAC.

Companies using Signant SmartSignals eCOA range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 0%, large organizations with 1,001-10,000 employees - 50%, and global enterprises with 10,000+ employees - 50%.

Customers of Signant SmartSignals eCOA include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Signant SmartSignals eCOA customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.